Prelude Therapeutics
PRLD
#8532
Rank
โ‚น23.96 B
Marketcap
โ‚น299.29
Share price
-0.77%
Change (1 day)
100.04%
Change (1 year)

EPS for Prelude Therapeutics (PRLD)

EPS in 2026 (TTM): -โ‚น83.68

According to Prelude Therapeutics's latest financial reports the company's current EPS (TTM) is -โ‚น87.10. In 2025 the company made an earnings per share (EPS) of -โ‚น119.53 an increase over its 2024 EPS that were of -โ‚น155.67.

EPS history for Prelude Therapeutics from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น83.68-29.99%
2025-โ‚น119.53-23.21%
2024-โ‚น155.67-16.83%
2023-โ‚น187.17-17.21%
2022-โ‚น226.090.41%
2021-โ‚น225.16-46.71%
2020-โ‚น422.53435.92%
2019-โ‚น78.8486.09%
2018-โ‚น42.37

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
-โ‚น125.09 43.62%๐Ÿ‡บ๐Ÿ‡ธ USA